Package 0615-8587-39

Brand: divalproex sodium

Generic: divalproex sodium
NDC Package

Package Facts

Identity

Package NDC 0615-8587-39
Digits Only 0615858739
Product NDC 0615-8587
Description

30 TABLET, DELAYED RELEASE in 1 BLISTER PACK (0615-8587-39)

Marketing

Marketing Status
Marketed Since 2025-08-15
Brand divalproex sodium
Generic divalproex sodium
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3898a9c6-b4ac-4240-94f1-3c76a3df6770", "openfda": {"unii": ["644VL95AO6"], "rxcui": ["1099625", "1099678", "1099870"], "spl_set_id": ["f936b9d0-a58f-4fa5-8db9-752dabb837a6"], "manufacturer_name": ["NCS HealthCare of KY, LLC dba Vangard Labs"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, DELAYED RELEASE in 1 BLISTER PACK (0615-8587-39)", "package_ndc": "0615-8587-39", "marketing_start_date": "20250815"}], "brand_name": "divalproex sodium", "product_id": "0615-8587_3898a9c6-b4ac-4240-94f1-3c76a3df6770", "dosage_form": "TABLET, DELAYED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "0615-8587", "generic_name": "divalproex sodium", "labeler_name": "NCS HealthCare of KY, LLC dba Vangard Labs", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "divalproex sodium", "active_ingredients": [{"name": "DIVALPROEX SODIUM", "strength": "250 mg/1"}], "application_number": "ANDA078853", "marketing_category": "ANDA", "marketing_start_date": "20240626", "listing_expiration_date": "20261231"}